Ilaria Andreana, Marta Chiapasco, Valeria Bincoletto, Sabrina Digiovanni, Maela Manzoli, Caterina Ricci, Elena Del Favero, Chiara Riganti, Silvia Arpicco, Barbara Stella
Biodegradable nanocarriers possess enormous potential for use as drug delivery systems that can accomplish controlled and targeted drug release, and a wide range of nanosystems have been reported for the treatment and/or diagnosis of various diseases and disorders. Of the various nanocarriers currently available, liposomes and polymer nanoparticles have been extensively studied and some formulations have already reached the market. However, a combination of properties to create a single hybrid system can give these carriers significant advantages, such as improvement in encapsulation efficacy, higher stability, and active targeting towards specific cells or tissues, over lipid or polymer-based platforms...
May 6, 2024: Drug Delivery and Translational Research